Dr Dean Semmens obtained a first-class degree in Molecular and Cellular Biology at the University of Bath, where he also spent time at Eli Lilly as part of a neurodegeneration drug-hunting team focusing on targets in Alzheimer’s and Parkinson’s disease. He obtained a PhD in Neuroscience and subsequently undertook two Postdoctoral Research Assistant positions at Queen Mary University of London. Following a position as a Lecturer in Neuroscience at Barts and the London, Dr Semmens joined St George’s University of London.

Dr Dean Semmens’ research focusses on understanding the function and evolution of neuropeptide signalling systems. Dr Semmens has published his research in several scientific journals (e.g. BMC Biology) and has been invited to give talks in both European (e.g. Conference of European Comparative Endocrinology) and International (e.g. International Congress of Comparative Endocrinology) conferences.

Dr Dean Semmens currently leads the Life Control module on the Medicine degree programme, whilst also leading The Central Nervous System, Mental Health, Gut and Skin module on the Pharmacy (with Kingston University) degree programme and the Foundations of Clinical Neuroscience module on the Clinical Neuroscience Practice degree programme. Dr Semmens teaches and supervises students in the areas of neuroscience and pharmacology on the Biomedical Science, Clinical Pharmacology, Medicine, and Pharmacy degree programmes.

Dr Semmens has obtained a Certificate in Learning and Teaching (CILT) at Queen Mary University of London and a PGCert in Healthcare and Biomedical Education at St George’s University of London, leading to Fellowship of Advance HE.